
zzso zzso has been demonstrated to prevent zzso of zzso zzso virus zzso infections when administered zzso to zzso bone zzso transplant zzso recipients or patients undergoing stem cell rescue zzso zzso zzso which is converted in the body to zzso has greater oral zzso than oral zzso and compared with oral zzso yields similar zzso plasma zzso with less frequent zzso zzso This study compared the efficacy of oral zzso with that of oral zzso at preventing zzso zzso in zzso zzso A total of 60 zzso patients scheduled for zzso or stem cell rescue therapy were treated zzso with zzso 500 zzso twice daily until resolution of zzso Data from these patients were compared with those of a historical control group of 60 patients who had received zzso 600 zzso every 6 h until resolution of zzso or zzso 125 zzso zzso every 6 zzso The results show that none of the patients developed oral or zzso zzso infection while receiving either zzso Of the 60 patients receiving zzso 38 zzso completed treatment without the need for intravenous zzso compared with 12 of 60 zzso patients in the zzso zzso Additionally, the total number of doses of drug administered to the zzso group was significantly less than the number received by patients in the zzso zzso No serious adverse events occurred in either group of zzso This study demonstrates that oral zzso and zzso are comparably effective and safe in preventing zzso of zzso infections in zzso zzso and stem cell zzso The less frequent dosing schedule with zzso compared with zzso offers a potential advantage for patients undergoing zzso who frequently suffer with severe zzso and have difficulty taking oral zzso 

